Altium Capital Management »

Praxis Precision Medicines I shares owned by Altium Capital Management

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 78k 61.02

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New (ALIM)
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Praxis Precision Medicines I

Adage Capital Partners GP
BlackRock
RA Capital Management
Point72 Asset Management
Vanguard Group
T. Rowe Price Associates
State Street Corporation
Perceptive Advisors
Verition Fund Management
VR Adviser
Cormorant Asset Management
Soleus Capital Management
Partner Fund Management
FMR
Vestal Point Capital

View all funds holding Praxis Precision Medicines I